Expression of CAS/CSE1L, the Cellular Apoptosis Susceptibility Protein, Correlates With Neoplastic Progression in Barrett's Esophagus

被引:1
|
作者
Jiang, Kun
Cowden, Daniel
Neill, Kevin G.
Klapman, Jason B.
Eschrich, Steven
Pimiento, Jose M.
Malafa, Mokenge P.
Coppola, Domenico
机构
关键词
D O I
10.1016/S0016-5085(16)31659-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Su1145
引用
下载
收藏
页码:S482 / S483
页数:2
相关论文
共 50 条
  • [41] Aberrant p53 protein expression is associated with an increased risk of neoplastic progression in patients with Barrett's oesophagus
    Kastelein, Florine
    Biermann, Katharina
    Steyerberg, Ewout W.
    Verheij, Joanne
    Kalisvaart, Marit
    Looijenga, Leendert H. J.
    Stoop, Hans A.
    Walter, Laurens
    Kuipers, Ernst J.
    Spaander, Manon C. W.
    Bruno, Marco J.
    GUT, 2013, 62 (12) : 1676 - 1683
  • [42] CDx2 Expression Reduces Disease Progression in the L2-IL-1Beta Mouse Model for Barrett's Esophagus
    Kong, Jianping
    Crissey, Mary Ann S.
    Jhala, Nirag
    Bortner, James D.
    Falk, Gary W.
    Rustgi, Anil K.
    Wang, Timothy C.
    Lynch, John P.
    GASTROENTEROLOGY, 2014, 146 (05) : S308 - S309
  • [43] Aberrant promoter methylation silences secreted-frizzled related protein genes and occurs early during neoplastic progression of Barrett's esophagus
    Zen, HZ
    Harrington, JJ
    Molini, JR
    Osborn, NK
    Burgart, LJ
    Klatt, KK
    Ahlquist, DA
    GASTROENTEROLOGY, 2004, 126 (04) : A177 - A177
  • [44] Altered expression of CD44 and DKK1 in the progression of Barrett’s esophagus to esophageal adenocarcinoma
    T. Darlavoix
    W. Seelentag
    P. Yan
    A. Bachmann
    F. T. Bosman
    Virchows Archiv, 2009, 454 : 629 - 637
  • [45] Altered expression of CD44 and DKK1 in the progression of Barrett's esophagus to esophageal adenocarcinoma
    Darlavoix, T.
    Seelentag, W.
    Yan, P.
    Bachmann, A.
    Bosman, F. T.
    VIRCHOWS ARCHIV, 2009, 454 (06) : 629 - 637
  • [46] Increasing cyclooxygenase-2 (cox-2) gene expression in the progression of Barrett's esophagus to adenocarcinoma correlates with that of Bcl-2
    Shimizu, Daisuke
    Vallboehmer, Daniel
    Kuramochi, Hidekazu
    Uchida, Kazumi
    Schneider, Sylke
    Chandrasoma, Parakrama T.
    Shimada, Hiroshi
    DeMeester, Tom R.
    Danenberg, Kathleen D.
    Peters, Jeffrey H.
    DeMeester, Steven R.
    Danenberg, Peter V.
    INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (04) : 765 - 770
  • [48] Cellular apoptosis susceptibility protein (CAS) suppresses the proliferation of breast cancer cells by upregulated cyp24a1
    Mei Ye
    Ruigang Han
    Jianwu Shi
    Xunda Wang
    Allan Z. Zhao
    Fanghong Li
    Hao Chen
    Medical Oncology, 2020, 37
  • [49] Cellular apoptosis susceptibility protein (CAS) suppresses the proliferation of breast cancer cells by upregulated cyp24a1
    Ye, Mei
    Han, Ruigang
    Shi, Jianwu
    Wang, Xunda
    Zhao, Allan Z.
    Li, Fanghong
    Chen, Hao
    MEDICAL ONCOLOGY, 2020, 37 (05)
  • [50] Synergic CSE1L/CAS, TNFR-1, and p53 apoptotic pathways in combined interferon-γ/adriamycin-induced apoptosis of Hep G2 hepatoma cells
    Jiang, M. C.
    Luo, S. F.
    Li, L. T.
    Lin, C. C.
    Du, S. Y.
    Lin, C. Y.
    Hsu, Y. W.
    Liao, C. F.
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2007, 26 (01) : 91 - 99